# MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer

> **NCT01992861** · — · TERMINATED · sponsor: **University of Washington** · enrollment: 51 (actual)

## Conditions studied

- Cervical Adenocarcinoma
- Cervical Adenosquamous Carcinoma
- Cervical Squamous Cell Carcinoma, Not Otherwise Specified
- Cervical Undifferentiated Carcinoma
- Recurrent Cervical Carcinoma
- Stage IB2 Cervical Cancer
- Stage II Cervical Cancer
- Stage IIA Cervical Cancer
- Stage IIB Cervical Cancer
- Stage III Cervical Cancer
- Stage IIIA Cervical Cancer
- Stage IIIB Cervical Cancer
- Stage IVA Cervical Cancer

## Interventions

- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Diffusion Weighted Imaging
- **PROCEDURE:** Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- **RADIATION:** Fludeoxyglucose F-18
- **PROCEDURE:** Magnetic Resonance Spectroscopic Imaging
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT01992861
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02-14
- **Primary completion:** 2022-01
- **Final completion:** 2022-01
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2023-06-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01992861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01992861, "MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01992861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*